Uncategorised - European Medical Journal

Genetic Study Questions Alcohol’s Role in Fatty Liver: EASL 2025

The findings suggest that lifestyle factors beyond alcohol, such as diet and physical inactivity, may play a more substantial role in fatty liver development.

AAN 2025 Interview: Larry B. Goldstein

Larry B. Goldstein – Judy and Byron Young Neuroscience Institute Endowed Professor, Chair of the Department of Neurology, Associate Dean…

AMJ Podcast | Episode 1: Harnessing Imaging Biomarkers in Asthma: Lessons from VESTIGE

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the…

Reversible Cerebral Vasoconstriction Syndrome Presenting with Multifocal Infarcts

Reversible cerebral vasoconstriction syndrome (RCVS) is a rare and underdiagnosed cause of multifocal infarcts, characterized by transient…

Lessons from Respiratory Viruses: Interview with Peter Openshaw

Peter Openshaw | Proconsul, Professor of Experimental Medicine, National Heart & Lung Institute – Faculty of Medicine, Imperial…

Neurocritical Care Innovations: Interview with Ryan Hakimi

Ryan Hakimi – President American Society of Neuroimaging (ASN); Executive Committee Member, Neurocritical Care Society Board of Directors…

AI-Powered Pathology Tool Improves Pediatric Sarcoma Diagnosis: AACR 2025

AI-based models analyzing digital pathology images may offer a major leap in pediatric sarcoma diagnosis accuracy, according to research presented at the American Association for Cancer Research Annual Meeting 2025.

Parkinson’s Risk May Rise Near Golf Courses

Living near golf courses may significantly increase the risk of Parkinson’s disease, according to new research analyzing data from the Rochester Epidemiology Project.

Diu Nguyen

Hema Now: Episode 16: A Journey Through Leukaemia Research

Diu Nguyen, Lecturer and Group Leader at the Centre for Haemato-Oncology, Barts Cancer Institute, joins the podcast to discuss breakthroughs in acute myeloid leukaemia (AML) research

SGLT2 Inhibitors Reduce Hyperkalaemia Risk in RAASi Use

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.